Showing results (91-100 of 101) with videos related to
Sort By:
Pageof 11
Blood Advances|July 10, 2026
Germline landscape stratification defines distinct molecular and prognostic groups in therapy related myeloid neoplasmsOriol Calvete, Julia Mestre, Lorea Chaparro-González, et al.Leukemia Research|January 23, 2013
Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: does -7/7q- detection by FISH have prognostic value?Vera Ademà, Jesús María Hernández, María Abáigar, et al.Haematologica|July 2, 2008
Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-Mar Mallo, Leonor Arenillas, Blanca Espinet, et al.Leukemia Research|June 17, 2021
Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL)Eulàlia Genescà, Mireia Morgades, Celia González-Gil, et al.Haematologica|November 3, 2022
Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trialsCelia González-Gil, Mireia Morgades, Thaysa Lopes, et al.Blood|July 3, 2024
Molecular taxonomy of myelodysplastic syndromes and its clinical implicationsElsa Bernard, Robert P Hasserjian, Peter L Greenberg, et al.NEJM Evidence|February 6, 2024
Molecular International Prognostic Scoring System for Myelodysplastic SyndromesElsa Bernard, Heinz Tuechler, Peter L Greenberg, et al.Nature Medicine|August 5, 2020
Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromesElsa Bernard, Yasuhito Nannya, Robert P Hasserjian, et al.Nature Communications|October 30, 2021
Genome-wide association study identifies susceptibility loci for acute myeloid leukemiaWei-Yu Lin, Sarah E Fordham, Eric Hungate, et al.Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|January 28, 2014
[National guidelines of diagnosis and treatment of the non-Hodgkin lymphoma]Myrna Candelaria, Eduardo Cervera-Ceballos, Abelardo Meneses-García, et al.Pageof 11